EMEA-002283-PIP01-17-M02

Table of contents

Key facts

Active substance
  • Aztreonam (ATM)
  • Avibactam (AVI)
Therapeutic area
Infectious diseases
Decision number
P/0350/2021
PIP number
EMEA-002283-PIP01-17-M02
Pharmaceutical form(s)
Powder for concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of infections caused by aerobic gram-negative bacteria
Route(s) of administration
Intravenous use
Contact for public enquiries
Pfizer Europe MA EEIG

Tel. +44 1304 6466 07
E-mail: pip_enquiries@pfizer.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating